Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
about
Pulmonary fibrosis: pathogenesis, etiology and regulationRoles of ICAM-1 for abnormal leukocyte recruitment in the microcirculation of bleomycin-induced fibrotic lung injury.Intestinal and liver toxicity of antineoplastic drugs.IL-9 protects against bleomycin-induced lung injury: involvement of prostaglandins.Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer.Bleomycin and the skin.Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial.Radioimmunoassay of bleomycin in plasma and urine.The pharmacokinetics of bleomycin in man.Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.Ultrasensitive fluorescence detection of bleomycin via exonuclease III-aided DNA recycling amplification.The Bleomycin Model of Pulmonary Fibrosis.Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).Increased Pulmonary FDG Uptake in Bleomycin-Associated Pneumonitis
P2860
Q28388425-F952AA10-4862-4A9C-A35B-CB7170E1A93BQ30870025-A29947BE-2FE5-44F5-8E78-D3D2805CF9AAQ33605823-8525DC3D-5962-46E4-8116-4E17F6DBDDA9Q35083565-99B53B55-F5A9-47E5-A8DF-F71599AF8739Q35570990-98B42A20-02FF-477D-A50D-06FF14832144Q36620749-DDD0F15A-6BD6-4E7A-B5A4-CBE67056D66EQ37612347-BE7BF194-C6BE-4B8D-B5F7-76BCAF063F9EQ38287745-B9A24B8A-8582-461C-9598-EA8BBCD64E31Q39245878-D7835D3D-1D50-4FA4-A9C6-4A9AE209ADD5Q39440575-2906DCB2-F374-4784-9C59-98198DB7AB0AQ39497594-EF098133-FE3E-44FA-A480-9C04A5E169BFQ41788710-E0F5262C-44DB-4C21-B6A2-C517FE795DF9Q46237692-D871FC64-348A-4028-A5D8-FDD307DD6897Q47794291-4E3C12EC-D4AF-4188-8C78-3EBA582901F1Q50711133-272D3090-642C-4CF4-8E0D-D4A420497D7FQ57728695-EE8067AA-B027-4318-97BB-D83E98C05CF6
P2860
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh-hant
name
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
@en
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
@nl
type
label
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
@en
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
@nl
prefLabel
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
@en
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
@nl
P2093
P1433
P1476
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
@en
P2093
P304
P356
10.1002/1097-0142(197405)33:5<1230::AID-CNCR2820330507>3.0.CO;2-C
P407
P577
1974-05-01T00:00:00Z